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Background: The EURRECA (EURopean micronutrient RECommendations Aligned) Network of Excellence (http://
www.eurreca.org) is working towards the development of aligned recommendations. A protocol was required to assign
resources to those micronutrients for which recommendations are most in need of alignment.
Methods: Three important ‘a priori’ criteria were the basis for ranking micronutrients: (A) the amount of new scientific evidence,
particularly from randomized controlled trials; (B) the public health relevance of micronutrients; (C) variations in current
micronutrient recommendations. A total of 28 micronutrients were included in the protocol, which was initially undertaken
centrally by one person for each of the different population groups defined in EURRECA: infants, children and adolescents,
adults, elderly, pregnant and lactating women, and low income and immigrant populations. The results were then reviewed and
refined by EURRECA’s population group experts. The rankings of the different population groups were combined to give an
overall average ranking of micronutrients.
Results: The 10 highest ranked micronutrients were vitamin D, iron, folate, vitamin B12, zinc, calcium, vitamin C, selenium,
iodine and copper.
Conclusions: Micronutrient recommendations should be regularly updated to reflect new scientific nutrition and public health
evidence. The strategy of priority setting described in this paper will be a helpful procedure for policy makers and scientific
advisory bodies.
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Background
Need for evidence-based policy development
National and international scientific nutrition advisory
bodies function as an interface between policy makers and
the scientific community as they are charged with providing,
interpreting and advising governments on the evidence base
for policy decisions. However, there is often limited clarity
on how nutrition-related requests are framed and selected by
policy decision makers to submit to these advisory bodies.
Moreover, the development of modern health policies relies
on evidence-based recommendations to (i) make policies
more efficient and reasonable and (ii) ensure greater
accountability for decisions. As advisory bodies are bound
by practical constraints such as limited resources, predefined
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prioritization tools would be helpful to guide policy makers
in making evidence-based, transparent requests to advisory
bodies.
Revision of nutrient recommendations
One of the requests made by governments to policy advisory
bodies such as the European Food Safety Authority or
other (inter)national nutrient recommendation setting
bodies is the updating of micronutrient intake reference
values, including the Average Nutrient Requirement (ANR)
and the Individual Nutrient Level (INL97,5), otherwise known
as ‘recommendations’, or population reference intakes or
dietary reference intakes (Dhonukshe-Rutten et al., 2010).
The revision of reference intake values on the basis of the
best and most recent available evidence is a costly process
for advisory bodies in terms of expert time and money.
Therefore, a systematic prioritization process may need to be
applied to decide those micronutrients on which to focus.
Many advisory bodies responsible for setting recom-
mendations acknowledge that (changes in) public health
consequences and new scientific evidence are important
indicators for prioritizing micronutrients for revision, but
they do not use transparent ‘a priori’ criteria. The need
to incorporate transparent ‘a priori’ criteria into strategies
for future reviews of micronutrient recommendations has
recently been highlighted by several international groups of
researchers (Lambert and Ashwell, 2010; Yetley et al., 2009).
This paper addresses the development and use of a
protocol for identifying priority micronutrients for the
purpose of reviewing dietary recommendations.
This work was undertaken within the context of the
EURRECA (EURopean micronutrient RECommendations
Aligned) Network of Excellence (http://www.eurreca.org).
EURRECA is funded by the EU 6th Framework Programme, to
address the disparity in micronutrient recommendations
between countries.
Methods
Derivation of ‘a priori ‘criteria used for priority setting
The most important trigger for reviewing and revising
micronutrient recommendations for any organization
involved in, or responsible for, setting recommendations is
the availability of new scientific evidence on intake–status–
health indicator/outcome associations published since the
previous sets of values were established (Taylor, 2008; Yetley
et al., 2009). A second trigger relevant for policy makers is (a
change in) the public health burden of a particular micro-
nutrient. An additional trigger for EURRECA, in the European
context, was the need to align the scientific basis for
micronutrient recommendations across different countries.
These triggers were translated into the following criteria:
(a) amount of relevant, new scientific evidence available
for a particular micronutrient for different life-stage
population groups;
(b) public health relevance of the micronutrient for the
different population groups, including vulnerable
groups such as low income and immigrant population:
(c) heterogeneity defined as variations in current micronu-
trient recommendations in different European countries.
These three theoretical criteria were translated into
quantifiable indicators (see Figure 1 for schematic presenta-
tion). Once translated, the indicators were combined into
an assessment matrix as shown in Figure 2. The multi-
dimensional matrix was transformed into a priority pyramid
that includes the four cells of the matrix with the highest
attributed priority. Highest priority was given to micro-
nutrients for which the amount of new evidence was
substantial (A), were most relevant for public health (B)
and for which variations in current recommendations were
relatively large (C).
Translation of three theoretical criteria into quantifiable
indicators
The quantification of these three criteria was applied to
28 micronutrients reviewed previously by the US Institute of
Medicine (IOM) (Taylor, 2008), namely, vitamins A, D, E, K,
C, thiamin (B1), riboflavin (B2), niacin (B3), pyridoxine (B6),
cobalamin (B12), folic acid (B11), biotin, choline, calcium,
chromium, copper, fluoride iron, iodine, magnesium,
manganese, molybdenum, pantothenic acid, phosphorus
potassium, selenium, sodium and zinc.
Amount of new evidence
New evidence was quantified as the number of publications in
PubMed from 2003 onwards using two standardized search
strategies. To focus on recent evidence, searches were limited to
the period from 1 January 2003 to 15 July 2008. This point in
time was chosen because the micronutrient reference values
that were most recently published worldwide, including all
micronutrients, namely, those from Australia/New Zealand
(Ministry of Health, 2005), included scientific evidence up to
the end of 2002.1
The first standard search strategy performed on text words
in title[ti] and abstract[ab] was as follows: (Micronutrient
intake [ti, ab] OR Best Status marker [ti, ab]) AND Health
indicator [ti, ab] (for example, balance, health, growth,
factorial) AND NOT (patient [ti] OR patients [ti]) AND for
pregnancy and lactation only additional terms for example,
1Please note that this applied at the beginning of 2008 when we
started this study. Some countries, such as The Netherlands
(http://www.gezondheidsraad.nl/en/publications/healthy-nutri-





new recommendations for all micronutrients, or for a specific
micronutrient, after 2005.
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pregnan* [ti, ab] or lactat* [ti, ab] OR limitation to age group
of concern. The second search strategy was identical to the
first one, with the exception that this search was limited to
randomized controlled trials. This approach was chosen to
give more weight to the more robust scientific evidence
provided by such trials.
In the context of EURRECA, various micronutrient status
markers used to assess intake/exposure to and/or body levels
of each micronutrient were evaluated (Fairweather-Tait,
2008). A list of potential markers were collated in a table
and assigned a star rating by seeking the consensus of a
group of international micronutrient experts. Biomarkers
were rated as excellent (***), good (**), limited use (*) or
unacceptable (no star), and were also categorized according
to their usefulness either ‘in the field’ or in a research setting.
Biomarkers used or considered by the IOM (Food and
Nutrition Board, 1997–2003; Institute of Medicine, 2007;
Taylor, 2008) for setting recommendations for the United
States/Canada were included in the table, together with
others identified by Gibson (2006) and by international
experts.
The amount of new scientific evidence for all 28 micro-
nutrients was assessed separately for the five population
groups defined within the network, namely, (i) infants,
0- to 1-year olds; (ii) children and adolescents, 1- to 18-year
olds; (iii) pregnant and lactating women; (iv) adults, 18- to
64-year olds; and (v) the elderly, 65 years or older. For each
population group, the 14 micronutrients (50%) with the
highest ranking based on the number of hits of the two
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Figure 1 Schematic presentation of EURRECA’s protocol to prioritize the selection of micronutrients. aNot measured for micronutrients for
which the amount of new evidence (first criteria) was considered small for all population groups. *Database 1: Contained crude dietary intake
data from national surveys made available by ILSI Europe: Anonymous, 1998; Gregory et al., 2000; Serra-Majem and Aranceta, 2001–2006; Irish
Universities Nutrition Alliance, 2001; Turrini et al., 2001; Henderson et al., 2002; Mensink et al., 2002; Hulshof et al., 2004; Männistö et al., 2003;
Szponar et al., 2003; Lyhne et al., 2005; Irish Universities Nutrition Alliance, 2006; Ocké et al., 2008. Database 2: Held data from a EURRECA
literature review previously undertaken by Tabacchi et al, (2009). **Food and Nutrition Board, 1997–2003; World Health Organization, 2003;
Ministry of Health 2005; World Cancer Research Fund and American Institute for Cancer Research, 2007.
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evidence was considered ‘large’ as defined by the protocol
criteria.
For low income and immigrant populations, no specific
searches were carried out, as physiological requirements are
not expected to differ from the general population, and
studies on intake–status–health relationships are commonly
not focused specifically on these groups. Therefore, for this
population group, the ranking of micronutrients was based
on the total number of hits of all other (life stage)
populations. As a quality check, the titles of the publications
identified using the first search strategy for each micronu-
trient were screened for contributions of irrelevant publica-
tions, for example, relating to treatment of chronically ill
populations.
Public health relevance
Public health relevance for a particular micronutrient was
assessed using measures of dietary inadequacy and disease
burden, such as
(1) evidence from national representative or large popula-
tion samples for inadequacy of intake or poor status of a
micronutrient in five or more European countries;
(2) evidence (from meta-analyses or reviews) for an associa-
tion between the micronutrient and a severe health
problem, or an association between the micronutrient
and a mild health problem with high incidence in the
population. This was defined as nutrition-related health
outcomes causing the largest burden of diseases in
Europe as expressed in disability adjusted life years.
Public health concerns were considered the most relevant
if both criteria were applicable. However, micronutrients for
which limited data were available to assess inadequacy of
intake and status, but fulfilled only the second criterion,
were also accepted.
Public health relevance was not assessed for those micro-
nutrients for which only limited new evidence was available
for all population groups as described in the previous section
(that is, micronutrients with low priority, allocated to the ‘a’
column of the matrix shown in Figure 2).
Assessment of inadequacy of intake and poor status. Two
databases were created and used to assess inadequacy of
dietary intake:
Database 1: It contained crude dietary intake data from
national surveys. Data were available for 13 micronutrients
(calcium, copper, folate, iodine, selenium, zinc, vitamin A,
vitamin D, vitamin E, magnesium, niacin (B3), phosphorus,
pyridoxine (B6)) and for 9 countries for population groups
aged 4–10, 11–17 and 18þ years (Anonymous, 1998;
Gregory et al., 2000; Irish Universities Nutrition Alliance,
2001, 2006; Turrini et al., 2001; Serra-Majem and Aranceta,
2001–2006; Henderson et al., 2002; Mensink et al., 2002;
Männistö et al., 2003; Szponar et al., 2003; Hulshof et al.,
2004; Lyhne et al., 2005; ILSI Europe, 2008; Ocké et al.,
2008).
Database 2: It held data from a EURRECA literature review
previously undertaken by Tabacchi et al. (2009). This review
included observational studies and methodological papers
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Figure 2 Schematic presentation of the matrix and priority pyramid used for scientific triage.
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on dietary intake and adequacy measurements for 20
micronutrients, published between 1990 and 2008.
These two databases were used to evaluate the existence of
inadequacy for all available population groups. The Nordic
Nutrient Intake Values were used as reference values to
evaluate adequacy of intake, as they are the most recently
published European recommendations (Nordic Council of
Ministers, 2004).
The available intake data from the two databases (1: intake
of the 5th and 50th percentile; 2: mean/median intakes) and
the published reference values (INL97,5 , which is the ANR
plus 2 times the standard deviation, or Adequate Intake)
precluded the use of best practice methods to assess
inadequate intake as described by Roman-Viòas et al. (2009)
for all population groups. Therefore, a simplified method was
used. Some evidence for inadequacy was accepted:
 if the mean or median intake was less than 75% of the
INL97,5 , otherwise known as recommended dietary allow-
ance2 or
 if the intake of the fifth percentile was less than 50%
of the INL97,5 for five or more European countries.
On using these databases, adequacy and intake data for
some population groups and micronutrients were limited;
therefore, additional scientific input was required. This
involved an eminence-based judgement on inadequacy of
intake by a panel of EURRECA experts, all co-authors of
this paper, on nutritional requirements in each population
group. Moreover, the experts were asked to assess the
inadequacy of the micronutrient status for their population
group and to (re)classify micronutrient inadequacies on the
basis of additional evidence from literature. No specific
guidelines were provided to the expert panel.
Evidence for association with health outcomes causing the largest
burden of disease. Nutrient-related health outcomes causing
the greatest burden of disease in Europe, as expressed in
disability adjusted life years, are cardiovascular, respiratory
and neuropsychological diseases, cancer, osteoporosis, dia-
betes and, indirectly, suboptimal growth and development
during the entire lifespan (World Health Organization, 2001,
2003, 2004b). Three different sources were consulted for
evidence of associations between each micronutrient and
one or more health outcomes:
(1) Micronutrient reports from the United States/Canada
and Australia/New Zealand: these reports provided an
overview of chronic diseases that may be associated with
micronutrients (Food and Nutrition Board, 1997–2003;
Ministry of Health, 2005).
(2) Recent reports of international organizations; such as
the World Health Organization and the World Cancer
Research Foundation, were screened for their conclu-
sions on the evidence base for these associations (World
Health Organization, 2003; World Cancer Research Fund
and American Institute for Cancer Research, 2007).
(3) Reviews and meta-analysis identified from the PubMed
database since 1 January 2003 for the different micro-
nutrients.
We judged that there was ‘evidence’ for an association if
the authors of the reports (source 1 and 2) concluded that
there was convincing or probable evidence for an associa-
tion, or if the authors reported the possibility of an
association that was supported by one or more recent
reviews and/or meta-analysis (not necessarily consistent over
all available publications) from the PubMed database.
Heterogeneity
Information on variations in current recommendations was
available from a previous EURRECA research activity and
published by Doets et al. (2008). Variations were quantified
by ‘spread ratio per micronutrient’, that is, the highest
recommended value divided by the lowest recommended
value. Ratios were calculated for specifically defined ages
(3 and 9 months, 5, 10, 15, 25, 50 and 70 years), males and
females, as well as for pregnant and lactating women.
Comparison of the recommendations was restricted to
European countries, and organizations that defined recom-
mendations themselves or in collaboration with other
countries ‘de novo’, that is, using teams of experts who
weighed the scientific evidence (Panel on DRVs of the
Committee on Medical Aspects of Food Policy, 1991; Food
and Nutrition Council, 1992; Commission of the European
Communities, 1993; German Nutrition Society et al., 2000;
Latvian Food Center, 2001; Guéguen, 2001; Health Council
of the Netherlands, 2000, 2003; Nordic Council of Ministers,
2004; World Health Organization and Food and Agriculture
Organization, 2004a; Doets et al., 2008). As recommenda-
tions usually consist of values, ranges and multiple values
that apply to one population group (for example, values for
different activity levels), standardization procedures were
defined to enable a comparison of the recommendations as
described elsewhere (Doets et al., 2008).
Heterogeneity was defined for the total population, and
not per population group, as it should indicate general
misalignment. Heterogeneity was considered large when
(1) the spread ratio was X2 for all populations groups, or (2)
the spread ratio value was X2.5 for at least one population
group and X2 for two out of three of all populations groups.
These cutoff points were defined after reviewing the range of
spread ratios.
Priority matrix
The scientific triage methodology developed was undertaken
centrally by the first author to produce matrices (see Figure 2)
that were completed for each EURRECA population group
(infants, children and adolescents, adults, elderly, pregnant
275% was chosen, as on an average the ANR (published together
with the INL97,5 for adults and for a selection of micronutrients
only) was 75% of the INL97,5.
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and lactating women, low income and immigrant popula-
tions). Subsequently, each matrix was reviewed, and refined
by EURRECA’s population group experts, on the basis of their
extensive knowledge of the specific published literature for
that group. Finally, these matrices were combined to produce
an overall ranking of micronutrients. Micronutrients were
given a score of 1 if they were allocated to cell ABC of the
matrix, 2 for cell ABc, 3 for cell AbC, 4 for cell Abc and 5
if they were assigned to other cells (Figure 2). The final
ranking order was based on the total score of the micro-
nutrient, allocating an equal rank to micronutrients with
an equal score.
Results
Amount of new evidence
Micronutrients for which the amount of new evidence was
large for all of the five population groups were calcium,
folate, iodine, iron, selenium, zinc, vitamin D and
choline (ranked in the top 14). Evidence for sodium,
vitamin A, vitamin B12, vitamin E, vitamin C and copper
was large for four out of five population groups, and
evidence for magnesium, vitamin K, thiamine and fluoride
was large in one out of five population groups. For all
other micronutrients, the evidence was small in all popula-
tion groups.
Screening of the titles of papers showed that sodium
publications were mainly related to risks of high intake
rather than to evidence to estimate minimal physiological
needs for optimal health. As upper limits are not within the
scope of EURRECA, sodium was excluded from the list of
micronutrients for which the amount of evidence was
considered as ‘large’.
Public health relevance
Evidence for inadequate micronutrient intake or status. On the
basis of databases 1 and 2, we found some evidence for
inadequacy for one or more life-stage population groups for
calcium (children and adolescents, elderly), folate (children
and adolescents, adults, elderly, pregnant and lactating
women), iron (children and adolescents, adults, elderly,
pregnant and lactating women), zinc (infants, children and
adolescents, adults), vitamin D (children and adolescents,
adults), vitamin E (adults) and copper (adults). From the
expert consultation, we concluded that there was additional
evidence on inadequacy in the elderly population group for
vitamin D and vitamin B12 (inadequate status) (Holick,
2007; McLean et al., 2008), and for infants for vitamin D and
iron (inadequate status) (Brunvand and Brunvatne, 2001;
Pal and Shaw, 2001; Scientific Committee on Food, 2003;
WHO global database on anaemia, 2008a). Moreover, for low
income and immigrant populations, additional evidence
for inadequate intake was available for iodine, vitamin C,
vitamin A, vitamin E and magnesium (James et al, 1997;
DeLange et al., 2000; Brussaard et al., 2001; McNeill et al.,
2002; Pavlović et al., 2005; Andrieu et al., 2006; Nelson et al.,
2007; World Health Organization and UNICEF 2007;
Rasmussen et al., 2008; Zimmermann, 2009).
Evidence for association with health outcomes causing the largest
burden of disease. Table 1 provides an overview of available
information on the association between each micronutrient
and nutritionally related health problems most relevant in
Europe from the three different sources of information/
references. For most micronutrients, we concluded that there
was evidence available for an association with one or more
relevant micronutrient-related diseases in Europe. No evi-
dence was found for choline, copper, phosphorus and
thiamine.
Public health relevance, which was considered important
if both criteria described above applied, was overall highly
relevant for vitamin D and iron (all population groups),
followed by zinc and folate (five out of six population
groups), and calcium (four out of six population groups).
Heterogeneity
‘Spread ratios’ to quantify heterogeneity were calculated for
27 out of 28 micronutrients. Ratios for choline could not be
defined as none of the reports included recommendations
for this micronutrient. Heterogeneity was large for vitamin
D, vitamin C, sodium, folate, selenium, copper, iron, zinc,
phosphorus, vitamin B12, fluoride, biotin, chromium and
molybdenum. Figures 3a and b show the ‘spread ratios’ for
females and males, respectively, for the micronutrients for
which heterogeneity (C) and the amount of new evidence
were considered to be large (A). Because of the ‘zero’
recommendation for various age and population groups in
the United Kingdom for dietary vitamin D intake, the ratios
for vitamin D were often infinity and thus could not be
included in the graph.
Overall ranking of micronutrients
Table 2 shows the completed priority matrix for the different
population groups. Collating and summarizing information
for all population groups resulted in an overall ranking of
micronutrients. The top 10 micronutrients were vitamin D,
iron, folate, vitamin B12, zinc, calcium, vitamin C, selenium,
iodine and copper.
Discussion
Scientific triage tool for prioritizing micronutrients
We have described the development and use of a transparent
scientific triage protocol for establishing priority micronu-
trients for reviewing dietary requirements. Three key criteria
were derived ‘a priori’ from triggers relevant for bodies
responsible for setting nutrient recommendations, as well
as from EURRECA’s guiding principles. The key criterion
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‘new evidence’ is also recognized by other experts involved
in priority setting for reviewing nutrient intake values
(Yetley et al., 2009), whereas the concept of ‘burden of the
disease’ is a criterion often included in tools for priority
setting for health-care research and policy (Global Forum for
Health research, 2000; World Health Organization, 2008b).
We defined the three criteria such that they were easily
measurable and reproducible in a short time frame. However,
despite striving to develop an objective method, the
involvement of eminence-based expert opinion was still
required to compensate for the lack of a comprehensive
overview of micronutrient inadequacy in different popula-
tion groups in Europe. This means that our current method
is based on both evidence and eminence.
It could be suggested that the qualitative to quantitative
translation of criteria in the current protocol is not
sufficiently well founded. Alternatively, a more thorough
process could be set up to evaluate the amount of new
evidence, similar to the one described by Yetley et al. (2009)
who used ‘new evidence’ as a criterion to justify the review of
vitamin D requirements. Further, the method of accepting
evidence could be improved using, for example, guidelines
published by the Scottish Intercollegiate Guidelines Network
(http://www.sign.ac.uk/methodology/index.html). However,
the criteria used, and the extent to which sophisticated
measures are needed to measure them, will largely depend
on the context of priority setting and will vary depending on
the key question to be addressed. For EURRECA, the central
question was which micronutrients were most important to
be critically reviewed at this point in time, rather than justify
whether a review was needed. Given this central question,
the use of more sophisticated measures would not have
resulted in a different ranking order of micronutrients. This
is supported by the fact that the high priority given by IOM
to vitamin D (Chung et al., 2009) is in line with the high
ranking that we also obtained for this micronutrient.
Having completed the process, we do acknowledge that
the quality of our ‘simple’ measures could be improved, for
example, by extending the key terms in the search when
identifying the amount of new evidence (such as bioavail-
ability). Moreover, consideration might be given to consult-
ing more experts to identify relevant additional data sources/
evidence.
Use of overall ranking of micronutrients
We used the resulting overall ranking of micronutrients to
assign resources to micronutrients for which recommenda-
tions are most in need of alignment. Currently, EURRECA
systematic reviews relevant for estimating requirements on
intake–status–health indicator associations are being under-
taken for a subset of micronutrients (iron, zinc, folate,
vitamin B12, selenium and iodine). This subset of micro-
nutrients was driven by the priority ranking of micro-
nutrients, as well as by other factors such as (i) avoidance
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Table 2 Priority matrices completed for the different population groups















iron, zinc, vitamin C,
vitamin B12
ABc Calcium Calcium Calcium Calcium, iodine,






















































Biotin, chromium, manganese, molybdenum, niacin, phosphorus, sodium, pantothenic acida
ABC: new evidence, most relevant for public health, heterogeneous.
ABc: new evidence, most relevant for public health.
AbC: new evidence, heterogeneous.
Abc: new evidence.
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Figure 3 ‘Spread ratios’: highest recommended value divided by the lowest recommended value for (a) females and (b) males for
micronutrients for which the amount of evidence and heterogeneity was considered large (Because of the ‘zero’ recommendation for various age
and population groups in the United Kingdom for dietary vitamin D intake, the ratios for vitamin D were often infinity and thus could not be
included in the graph.).
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(for example, vitamin D and calcium reviews have been
initiated by IOM (Chung et al., 2009)), and (ii) micronutrient
expertise and (iii) available resources within the EURRECA
network (for these reasons, iodine and selenium were chosen
in preference to vitamin C).
Health indicators relevant to the selected micronutrients
have been identified and prioritized using public health
reports (Institute of Medicine, 2007; Ministry of Health,
2005) and scientific literature (current evidence of a relation-
ship, including the number of hits).
Translation to other projects
Priority setting is a frequently needed procedure for allo-
cating resources for health-related research and health care,
and yet several theoretical priority setting models in this
area have been developed, published, used, evaluated and
compared (Global Forum for Health Research, 2000; World
Health Organization, 2008b).
To our knowledge, this is the first tool developed to
explicitly address priority setting related to reviewing micro-
nutrient requirements, using clearly defined criteria and
translating qualitative into quantitative measures. It may
therefore be a useful example for scientific advisory bodies
responsible for reviewing micronutrient requirements and
subsequently setting recommendations. Moreover, the
newly developed protocol could be used as a model when
developing a strategy to prioritize other policy-related
questions for national and international scientific bodies
addressing nutrition and its relation to health. Although the
exact protocol will need modification, the main principle
with regard to the derivation of transparent measurable
criteria should remain.
Conclusion
Micronutrient recommendations must be regularly updated
to reflect new scientific evidence. However, resources are
often limited and an evidence-based transparent system is
needed for prioritization. The strategy of priority setting
described in this paper will provide a useful model for policy
makers and scientific advisory bodies.
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